Skip to content
Trial Eligibility
Menu

MASH / NASH (Fatty Liver Disease) Clinical Trials near New York, NY

20 studies for MASH / NASH (Fatty Liver Disease) are recruiting at 47 sites within 50 miles of New York, New York, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all MASH / NASH (Fatty Liver Disease) trials in the US or all trials near New York.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

MASH / NASH (Fatty Liver Disease) studies enrolling near New York

Showing 20 studies, nearest first.
  1. A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

    NCT07165028

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: IMA Clinical Research Manhattan (New York, NY); NYU Langone Health (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  2. A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

    NCT06215716

    • Phase 3
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Akero Clinical Study Site (New York, NY); Akero Clinical Study Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  3. A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

    NCT06528314

    • Phase 3
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Akero Clinical Study Site (New York, NY); Akero Clinical Study Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  4. A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

    NCT06318169

    • Phase 3
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: 89bio Clinical Study Site (New York, NY); 89bio Clinical Study Site (Warren Township, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  5. Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

    NCT05832229

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Columbia University Iriving School of Medicine (New York, NY); New York Presbyterian/Weill Cornell (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

    NCT06419374

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: 89bio Clinical Study Site (New York, NY); 89bio Clinical Study Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  7. A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

    NCT07221188

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: GSK Investigational Site (New York, NY); GSK Investigational Site (Jersey City, NJ)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  8. A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

    NCT07221227

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: GSK Investigational Site (New York, NY); GSK Investigational Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  9. Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

    NCT07335601

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: NY Presbyterian- Weill Cornell Medicine (New York, NY); Northwell Health Inc, Center for Liver Disease and Transplantation (Manhasset, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  10. Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

    NCT04054310

    • Interventional
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Icahn School of Medicine at Mount Sinai (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease

    NCT05332613

    • Interventional
    • Ages 18 to 65 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Weill Cornell Medicine (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

    NCT05519475

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Columbia University Irving Medical Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. High Fructose Diet, the Gut Microbiome, and Metabolic Health

    NCT06329544

    • Interventional
    • Ages 25 to 45 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Mount Sinai Morningside (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Human Models of Selective Insulin Resistance: Alpelisib, Part I

    NCT06354088

    • Phase 1
    • Ages 18 to 70 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Columbia University Irving Medical Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH

    NCT06920043

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: GSK Investigational Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. Effect of Insulin Lowering on Lipogenesis

    NCT07403604

    • Phase 1
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: Columbia University Irving Medical Center (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)

    NCT07704892

    • Phase 3
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: GSK Investigational Site (New York, NY)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

    NCT06632444

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NewYork-Presbyterian Brooklyn Methodist Hospital (Brooklyn, NY); Basil Clinical (Laurelton, NY)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  19. LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

    NCT06632457

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: NewYork-Presbyterian Brooklyn Methodist Hospital (Brooklyn, NY); Basil Clinical (Laurelton, NY)

    Distance to nearest recruiting site
    ~5 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  20. A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

    NCT07288138

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Premier Health Research (Sparta, NJ)

    Distance to nearest recruiting site
    ~40 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a MASH / NASH (Fatty Liver Disease) clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.